1. Presented by Neha GandhiYogender Arya 1 2. Bio-therapeutic products also known as biologic drugs have asuccessful record in treating many life-threatening and chronicdiseases.The…

Slide 1© 2010 Evalueserve, Ltd. All Rights Reserved - Privileged and Confidential IP Valuation April 2010 Dr. Rahul Verma, Assistant Vice President, Intellectual Property…

1.Christopher OhlyThe New India Guidelines on Similar Biologics The New India GuidelinesOn Similar Biologics Regulatory and Market Authorization Requirements By, Christopher…

Slide 1Drug Therapy for Rheumatoid Arthritis in Adults Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Slide 2  Introduction to drug treatment…

Slide 1 Preclinical Development Considerations for Biologics – Phase I Oncology Focus ODAC Meeting, March 13, 2006, Rockville, MD. James D. Green, Ph.D., DABT SVP – Preclinical…

Pharmacy-Contracts Steven Lucio, PharmD, BCPS December 9, 2015 A Clinicianâs Perspective Introduction to Biosimilars ©2014 Novation Confidential. â¹#⺠Question #1:…

Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis56 Abstract. – OBJECTIVE: Ankylosing Spon- dylitis (AS) is a